Sadhana Misar Wajpeyi

Protocol of Comparative Evaluation of Efficacy of Kulattha Gutika with Atorvastatin in the Management of Dyslipidemia (Medoroga)

Praveen Nandal & Sadhana Misar Wajpeyi · Journal of Pharmaceutical Research International · 2021

Introduction: The term 'Dyslipidemia' can be referred to Medoroga included under santarpanajanyavyadhi as per Ayurveda. In Dyslipidemia there is involvement of Tridosha with kaphadominance. Intake of unhealthy food, alcohol, cigarette smoking, stress and lack of physical activity...

Open access Research Article 10.9734/jpri/2021/v33i63B35251

Protocol on Comparative Efficacy of Bruhatyadi Kwath as Compared to Furosemide for Improving e –GFR and Albuminuria in Chronic Kidney Disease-A Randomized Controlled Study

Namrata Arvind Shankarpure, Sadhana Misar Wajpeyi, Sunil Kumar & Shamli Hiware · Journal of Pharmaceutical Research International · 2021

Background: The steady decrease of kidney function is referred to as chronic kidney disease. The kidney function is measured by Glomerular Filtration Rate (GFR). According to Ayurveda the CKD can be correlated to Mutraghatabecause of similarity of symptoms. In Ayurveda Mutraghata...

Open access Research Article 10.9734/jpri/2021/v33i63A35231

A Review on Role of Shaman Chikitsa in the Medoroga w.s.r to Dyslipidemia

Praveen Nandal, Sadhana Misar Wajpeyi & Khushhali Balpande · Journal of Pharmaceutical Research International · 2021

Background: Medoroga is a condition in which there is an excessive accumulation of Meda  Dhatu in the body. Accumulation of Medo Dhatu in different parts of the body causes blockage of Strotsa which ultimately leads to poor nourishment of other Dhathus. Lack of exercise and Kapha...

Open access Research Article 10.9734/jpri/2021/v33i60B34863